By Counterforce Health Team in Rylaze (asparaginase erwinia chrysanthemi [recombinant]-rywn) —

The Requirements Checklist to Get Rylaze (Asparaginase Erwinia Chrysanthemi) Covered by Aetna CVS Health in Ohio

Answer Box: Fast Track to Rylaze Coverage

Eligibility: Patients with ALL/LBL who developed hypersensitivity to E. coli-derived asparaginase. Fastest path: Submit Aetna's specialty drug prior authorization form via fax (1-888-267-3277) with documented hypersensitivity reaction and oncologist letter. First step today: Gather your hypersensitivity documentation and complete clinical records. Ohio advantage: 180-day appeal window with binding external review through Ohio Department of Insurance if denied.

Table of Contents

  1. Who Should Use This Checklist
  2. Member & Plan Basics
  3. Clinical Criteria Requirements
  4. Coding & Billing Essentials
  5. Documentation Packet
  6. Submission Process
  7. Specialty Pharmacy Routing
  8. After Submission: Tracking Your Request
  9. Denial Prevention Tips
  10. Appeals Process in Ohio
  11. Printable Checklist

Who Should Use This Checklist

This guide is designed for patients, caregivers, and healthcare teams seeking Aetna CVS Health coverage for Rylaze (asparaginase erwinia chrysanthemi [recombinant]-rywn) in Ohio. You'll benefit most if you:

  • Have acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL)
  • Previously experienced hypersensitivity to E. coli-derived asparaginase products
  • Need to navigate Aetna's prior authorization requirements
  • Want to avoid common denial reasons that delay treatment

Expected outcome: With complete documentation, over 95% of properly submitted requests receive approval within 24-72 hours.

Member & Plan Basics

Coverage Verification

Before starting your prior authorization request:

  • Confirm active Aetna coverage through your member portal or by calling the number on your insurance card
  • Identify your plan type: Commercial, Medicare Advantage, or Medicaid managed care affects your submission process
  • Check specialty drug benefits: Rylaze typically requires specialty pharmacy dispensing through CVS Specialty

Authorization Requirements

  • Prior authorization: Required for all Aetna plans
  • Formulary status: Usually non-formulary, requiring medical exception
  • Quantity limits: Based on FDA-approved dosing regimens
Note: Aetna processes specialty drug authorizations separately from standard medications through their dedicated team.

Clinical Criteria Requirements

Primary Indication Requirements

Your medical records must clearly document:

  1. Confirmed diagnosis of acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL)
  2. Documented hypersensitivity reaction to E. coli-derived asparaginase with specific clinical details
  3. Multi-agent chemotherapy regimen consisting of two or more agents
  4. Patient age ≥1 month (FDA requirement)

Hypersensitivity Documentation Standards

Aetna requires clinical evidence showing reactions such as:

  • Anaphylaxis or severe allergic reactions
  • Pancreatitis with amylase elevation ≥2 times upper limit of normal
  • Unresolved thrombotic or hemorrhagic events
  • Other clinically significant hypersensitivity reactions

Step Therapy Considerations

Patients must have failed or demonstrated hypersensitivity to E. coli-derived asparaginase first. Medical records from any healthcare facility showing documented hypersensitivity satisfy step therapy requirements.

Coding & Billing Essentials

Required Codes

Code Type Code Description
HCPCS (J-code) J9021 Injection, asparaginase, recombinant, (Rylaze), 0.1 mg
NDC 68727-900-03 10-digit NDC for billing
NDC (11-digit) 68727-0900-03 Alternative format

Diagnosis Codes (ICD-10)

  • ALL: C91.00 (not in remission), C91.01 (in remission), C91.02 (in relapse)
  • Lymphoblastic lymphoma: C83.50-C83.59 (site-specific)
  • Hypersensitivity: T78.40XA (unspecified allergy, initial encounter)

Billing Notes

  • Always submit both HCPCS J9021 and NDC codes to prevent claim denials
  • Use JW/JZ modifiers for drug wastage if applicable (single-dose vials)
  • Verify current codes with your billing department before submission

Documentation Packet

Provider Letter Requirements

Your oncologist's letter of medical necessity must include:

Patient Information:

  • Full name, date of birth, Aetna member ID
  • Complete diagnosis with staging information
  • Current weight and body surface area (for dosing calculations)

Clinical History:

  • Detailed description of hypersensitivity reaction to E. coli asparaginase
  • Dates of previous asparaginase treatments
  • Specific reaction symptoms and severity
  • Treatment received for the hypersensitivity reaction

Treatment Plan:

  • Planned chemotherapy regimen including all agents
  • Specific Rylaze dosing schedule (must align with FDA-approved regimens)
  • Expected treatment duration
  • Monitoring plan

Required Attachments

  • Office visit notes documenting hypersensitivity reaction
  • Laboratory results showing reaction (if applicable)
  • Hospital records if reaction required emergency treatment
  • Previous asparaginase treatment records
  • Current treatment protocol or clinical trial information
From our advocates: "The most successful appeals we've seen include a detailed timeline of the patient's asparaginase treatment history. When providers clearly document the date of the hypersensitivity reaction, the specific symptoms, and how it was managed, approval rates increase significantly. One composite case involved a patient whose initial denial was overturned within 48 hours after submitting emergency room records showing anaphylaxis to pegaspargase."

Submission Process

Correct Form Selection

Use Aetna's "Medical Exception/Prior Authorization/Precertification Request for Prescription Medications" form, available through:

Submission Methods

Method Details Timeline
Fax (Recommended) 1-888-267-3277 (specialty drugs) Fastest processing
Online Portal Availity.com provider portal Real-time status updates
Phone Support 1-855-240-0535 (M-F, 8 AM-6 PM CT) For urgent requests

Medicare Members

If you have Aetna Medicare Advantage, use the "2024 Request for Medicare Prescription Drug Coverage Determination" form and fax to 1-800-408-2386.

Common Submission Errors

  • Incomplete hypersensitivity documentation
  • Missing oncologist signature or credentials
  • Incorrect dosing calculations
  • Outdated form versions
  • Missing required attachments

Specialty Pharmacy Routing

CVS Specialty Coordination

Once approved, Rylaze typically routes through CVS Specialty pharmacy:

  1. Prescription transfer: Your oncologist sends the prescription to CVS Specialty
  2. Insurance verification: CVS Specialty confirms your prior authorization
  3. Shipment coordination: Cold-chain shipping arranged to your treatment facility
  4. Delivery confirmation: Verify receipt and proper storage temperature

Alternative Specialty Pharmacies

If your plan allows, other options may include:

  • Accredo Specialty Pharmacy
  • BioPlus Specialty Pharmacy
  • Local hospital specialty pharmacies (verify network status)

After Submission: Tracking Your Request

Confirmation Steps

  1. Record your confirmation number from fax or online submission
  2. Note submission date for tracking purposes
  3. Schedule follow-up for 3-5 business days if no response

Status Check Schedule

  • Day 3: Check status via Availity or call member services
  • Day 7: Contact provider services if no determination
  • Day 10: Consider peer-to-peer review request
  • Day 14: Prepare appeal documentation if denied

What to Record

Keep detailed notes including:

  • Submission confirmation numbers
  • Representative names and reference numbers
  • All communication dates and outcomes
  • Any additional documentation requests

Denial Prevention Tips

Five Common Pitfalls and Solutions

  1. Insufficient hypersensitivity documentation
    • Fix: Include detailed clinical notes with reaction timeline, symptoms, and treatment
  2. Missing oncologist credentials
    • Fix: Ensure board certification and contact information are clearly listed
  3. Dosing outside FDA parameters
    • Fix: Verify dosing aligns with approved regimens (25 mg/m² every 48 hours or M/W/F schedule)
  4. Incomplete prior therapy history
    • Fix: Document all previous asparaginase products tried and specific reactions
  5. Generic medical necessity language
    • Fix: Use patient-specific clinical details and reference Aetna's coverage criteria

At Counterforce Health, we help patients and providers navigate these exact challenges by creating targeted, evidence-backed appeals that address each payer's specific requirements.

Appeals Process in Ohio

Internal Appeal Timeline

  • First level: 30 days for standard appeals, 72 hours for urgent
  • Second level: Additional 30 days if first appeal denied
  • File within: 180 days of initial denial

External Review Process

Ohio offers robust external review rights:

Timeline: 180 days from final Aetna denial to request external review Process: File with Aetna, who forwards to Ohio Department of Insurance Decision time: 30 days standard, 72 hours expedited Outcome: Binding decision by Independent Review Organization (IRO)

Ohio Department of Insurance Resources

When to Escalate

Contact Ohio insurance regulators if:

  • Aetna improperly denies external review eligibility
  • Processing delays exceed stated timeframes
  • You need assistance with the appeals process

Printable Checklist

Before You Start

  • Active Aetna coverage confirmed
  • Insurance card and member ID ready
  • Complete medical records gathered
  • Oncologist contact information available

Clinical Documentation

  • ALL/LBL diagnosis confirmed with staging
  • Hypersensitivity reaction to E. coli asparaginase documented
  • Reaction details include date, symptoms, and treatment
  • Multi-agent chemotherapy regimen planned
  • Patient age ≥1 month confirmed

Forms and Submission

  • Current Aetna prior authorization form completed
  • Oncologist letter of medical necessity attached
  • All required clinical documentation included
  • Correct fax number used (1-888-267-3277 for specialty drugs)
  • Submission confirmation number recorded

Follow-up Actions

  • Status check scheduled for day 3-5
  • Appeal timeline noted (180 days in Ohio)
  • External review option documented
  • Ohio Department of Insurance contact saved

Frequently Asked Questions

How long does Aetna prior authorization take in Ohio? Standard decisions typically take 14 days, but urgent requests are processed within 72 hours. Most complete submissions receive approval within 24-48 hours.

What if Rylaze is non-formulary on my plan? You can request a formulary exception by documenting medical necessity and hypersensitivity to formulary alternatives.

Can I request an expedited appeal? Yes, if your physician certifies that delays would seriously jeopardize your health. Expedited appeals in Ohio receive decisions within 72 hours.

Does step therapy apply if I failed E. coli asparaginase outside Ohio? No, documented hypersensitivity from any healthcare facility satisfies Aetna's step therapy requirements.

What happens if my external review is denied? While the IRO decision is binding for insurance coverage, you retain rights to pursue other remedies, including regulatory complaints or legal action.

When patients face complex prior authorization challenges, Counterforce Health provides specialized support in turning insurance denials into successful appeals through targeted, evidence-based documentation that meets each payer's specific requirements.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance company for the most current requirements. Coverage decisions depend on individual medical circumstances and plan benefits.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.